Nightingale Health
What They Do[edit]
Blood testing platform that measures 250+ biomarkers from a single blood sample using NMR spectroscopy. AI-powered risk prediction for chronic diseases. Partnering with UK Biobank and Finnish biobanks.
Funding[edit]
Valuation: ~€300M+ (Nasdaq-listed) €100M+ raised. Nasdaq Helsinki listed.
Revenue[edit]
Source: allabolag.se / company reports